9. Omega-3 Fatty Acids
Omega-3 fatty acids protect not only the heart and brain but also reduce gut inflammation and favour a balanced microbiota.
Omega-3 Fatty Acids and the Gut – More Than a Heart Story
Omega-3s don’t just benefit your heart and brain – they nurture your gut microbiota too.
In 1970, two Danish researchers – Hans Olaf Bang, a physician, and Jørn Dyerberg, a biochemist – travelled to the remote Uummannaq district of northwestern Greenland with a specific clinical question. The Inuit population they were studying ate a diet that would have alarmed any cardiologist of the era: extraordinarily high in fat, almost entirely derived from marine mammals, fish, and seal blubber, with virtually no plant foods, no vegetables, and no grains. By every nutritional model of the time, they should have been dying of heart attacks at high rates. They were not. Danish hospital records showed that Greenlandic Inuit had cardiovascular event rates dramatically lower than mainland Danes, who ate far less fat by comparison. Bang and Dyerberg collected blood samples, transported them back to Copenhagen, and began analysing the fatty acid profiles. What they found was a lipid pattern unlike anything previously described in a human population: exceptionally high concentrations of two long-chain polyunsaturated fatty acids, which they identified as EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). [118] Their papers, published between 1971 and 1980, proposed that marine-derived omega-3 fatty acids were responsible for the Inuit's cardiovascular protection through anti-inflammatory and anti-thrombotic mechanisms. The work launched what became one of the most intensively studied areas in nutritional medicine. Subsequent decades of research confirmed that EPA and DHA reduce systemic inflammation, influence platelet aggregation, and modulate immune signaling – but also revealed that the picture is more complex. The Inuit's protection likely involved multiple dietary factors, and modern omega-3 clinical trials have shown more modest effects than the original Greenland data suggested. [119] What was not imagined in 1970 was that omega-3 fatty acids would turn out to have effects on the gut microbiota – a structure whose existence as a functional ecosystem was barely recognised. We now know that EPA and DHA influence the intestinal epithelial environment, reduce gut inflammation, and may modulate microbial composition indirectly through the host rather than acting as microbial substrates.
Patients often associate gut health with fiber or probiotics, but the intestinal ecosystem also responds to the type of fat we eat. Omega-3 fatty acids—especially EPA and DHA—are best known for their roles in inflammatory control, and this matters because inflammation strongly shapes the conditions in which gut microbes live [120].
EPA and DHA are found mainly in fatty fish such as salmon, sardines, and mackerel. Plant foods like flaxseed, chia, walnuts, and some vegetable oils provide ALA, which the body can convert to EPA and DHA only to a limited extent. In practice, this means that plant sources contribute to omega-3 intake, but they do not always lead to the same tissue levels as marine sources [121].
When researchers examine omega-3 intake and the gut microbiota in humans, they often see modest and variable changes. Some trials report shifts toward bacteria associated with short-chain fatty acid pathways, while others show little change in microbial composition and more change in metabolic readouts. This pattern suggests that omega-3s may influence the microbiota more through the host environment than by directly “adding” specific microbes [122][123].
A key part of the mechanism is how omega-3s are incorporated into cell membranes, including intestinal epithelial cells and immune cells. This can alter signaling and support the production of specialized mediators involved in resolving inflammation. In the gut, a calmer inflammatory tone may help maintain barrier function and mucus stability—conditions that support microbial balance [120].
Omega-3 intake has also been associated with changes in microbial metabolites in some settings. However, it is important to keep the hierarchy clear: dietary fiber remains the main substrate for short-chain fatty acid production, while omega-3s likely act as modulators that influence microbial networks indirectly.
Patients also ask about mood and cognition. Omega-3s have established biological roles in the nervous system, and gut-related pathways may contribute, but the gut–brain link is complex. It is more accurate to say that omega-3s can support systemic inflammatory balance, which may have downstream effects on well-being, rather than claiming a direct microbiota-driven improvement in mood.
As always, food context matters. Fish, nuts, and seeds provide omega-3s together with protein, minerals, and other fats that influence digestion and absorption. Supplements can be useful in selected clinical situations, but dose and safety considerations vary, especially for people on anticoagulants or with chronic disease.
In daily life, omega-3s work best as part of a broader pattern: regular sources of EPA/DHA where appropriate, combined with a plant-rich diet that supplies fermentable fibers. Omega-3s do not “feed” gut bacteria directly, but they may help maintain a stable intestinal environment in which beneficial microbial functions are more likely to persist.
Omega-3 Integration Strategies
In clinical nutrition, regular intake of fatty fish—such as salmon, sardines, mackerel, or herring—is often recommended because these foods provide EPA and DHA in forms that are readily utilized by the body.
Plant sources like flaxseed, chia seed, walnuts, and canola oil contribute alpha-linolenic acid, which complements marine omega-3 intake, although conversion to EPA and DHA is limited.
Attention is usually given to the overall fat pattern of the diet, since very high intake of omega-6-rich seed oils may counterbalance the anti-inflammatory effects of omega-3 fatty acids.
When dietary intake is insufficient or medically indicated, purified fish-oil or algae-derived supplements may be considered, with dosing tailored to the individual’s condition and medications.
Omega-3 intake appears most beneficial when it is part of a broader dietary pattern that includes vegetables, legumes, whole grains, and other fiber-rich foods, which support microbial fermentation and mucosal health.
In practice, consistent moderate intake is more important than occasional large doses, and whole-food sources provide additional nutrients that influence absorption and metabolism.
Microbiota Effects
- Omega-3 intake may modestly alter microbiota composition, with some studies reporting increased Bifidobacterium or Akkermansia muciniphila, although results are inconsistent across populations [122].
- Omega-3 fatty acids primarily act through host pathways—they reduce intestinal inflammation and may improve epithelial barrier function, indirectly shaping microbial communities [120].
- Anti-inflammatory lipid mediators derived from EPA and DHA can influence gut-associated immune activity (GALT), altering microbial tolerance rather than directly eliminating specific bacteria [120].
- Some studies report reduced circulating endotoxin markers after omega-3 supplementation, likely due to improved barrier integrity rather than direct antibacterial action [124].
- Omega-3s do not directly drive SCFA production; changes in SCFA profiles observed in studies are probably secondary to altered host metabolism and diet composition.
- The strongest microbial effects are seen when omega-3 intake is combined with fiber-rich diets, which provide substrates for SCFA-producing bacteria [122].
- Evidence for effects on fungi, archaea, or bacteriophages is limited and currently inconclusive.
- Overall, omega-3 fatty acids help maintain a microbiota-friendly environment by lowering inflammation and supporting mucosal health, rather than acting as probiotics or prebiotics.
Patient Guidance
- Try to eat fatty fish such as salmon, sardines, or mackerel about twice per week.
- Add small amounts of flaxseed, chia seed, or walnuts to meals during the week.
- Cook more often with olive oil instead of highly refined seed oils.
- Avoid deep-fried fish; choose baked, grilled, or steamed meals instead.
- If using omega-3 supplements, discuss dose and safety with your doctor first.
- Keep fish portions moderate and regular rather than occasional large servings.
- Combine omega-3 foods with vegetables, legumes, and whole grains.
- Note digestion, energy level, and mood changes in your diary.
- Review your diet if you take blood-thinning medication or have chronic illness.
- Remember: omega-3s support gut balance as part of an overall healthy diet.
References
[118] Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in north western Greenland. Am J Clin Nutr. 1980. Link
Duplicate diet samples from 50 adults (equal sex distribution) in north-western Greenland (1976) were analysed for water, ash, protein, fat, fatty acids, cholesterol, and carbohydrate, and compared with typical Danish diets. Seal and fish were the predominant foods. Eskimo diets were notably richer in polyunsaturated fatty acids, with a polyunsaturated/saturated fatty acid ratio of 0.84 versus 0.24 in Danes. The findings document the distinctive marine-fat-dominated nutritional profile underlying the low cardiovascular disease rates observed historically in this population.
[119] Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978. 1978. Link
Dyerberg, Bang, Stoffersen, Moncada and Vane's 1978 Lancet paper proposes that eicosapentaenoic acid (EPA) from marine diets prevents thrombosis and atherosclerosis. Building on epidemiological observations of low ischemic heart disease in Greenland Inuit despite high fat intake, they show that EPA competes with arachidonic acid in platelet eicosanoid pathways, generating less pro-aggregatory thromboxane and more vasodilatory prostacyclin-like compounds. The work provided the mechanistic foundation for the omega-3 cardiovascular hypothesis, motivating decades of clinical trials of fish-oil supplementation and dietary fish consumption. It remains a citation classic in nutritional cardiology.
[120] Calder, P. C. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017. Link
Review of omega-6 and omega-3 fatty acid roles in inflammation. EPA and DHA from oily fish or fish-oil supplements partly inhibit leucocyte chemotaxis, adhesion molecule expression, leucocyte-endothelial interactions, and the production of arachidonic-acid-derived eicosanoids and pro-inflammatory cytokines. EPA-derived eicosanoids are typically less potent than those from arachidonic acid, and EPA/DHA give rise to anti-inflammatory and inflammation-resolving mediators (resolvins, protectins, maresins), supporting their use in inflammatory conditions.
[121] Simopoulos, A. P. An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity. Nutrients. 2016. Link
Western diets have shifted from an omega-6/omega-3 ratio of 1:1 during human evolution to 20:1 or higher today, paralleling rising obesity prevalence. Experimental studies show divergent effects of omega-6 and omega-3 on adipogenesis, adipose-tissue browning, lipid homeostasis, brain-gut-adipose axis and systemic inflammation. Prospective studies confirm that higher omega-6 and a higher omega-6/omega-3 ratio in RBC membrane phospholipids increase obesity risk, while high omega-3 reduces it. Maintaining a balanced ratio is important for obesity prevention and management.
[122] Costantini L, Molinari R, Farinon B, Merendino N. Impact of Omega-3 Fatty Acids on the Gut Microbiota. Int J Mol Sci. 2017. Link
Long-term dietary habits shape host-specific gut microbiota, but dietary fat effects are less well characterised than those of carbohydrates. The few adult human omega-3 PUFA supplementation studies show consistent changes: decreased Faecalibacterium, increased Bacteroidetes and butyrate-producing Lachnospiraceae. Because dysbiosis of these taxa occurs in inflammatory bowel disease, omega-3 PUFAs may exert a beneficial effect by restoring microbial composition and increasing anti-inflammatory short-chain fatty acid production.
[123] Noriega BS, Sanchez-Gonzalez MA, Salyakina D, Coffman J. Understanding the impact of omega-3 rich diet on the gut microbiota. Case Rep Med. 2016. Link
Investigation of gut microbiota changes in response to an omega-3-rich diet, framed within the broader recognition that omega-3 polyunsaturated fatty acids ameliorate cardiometabolic, inflammatory and oncologic disorders. The benefits may be substantially mediated through diet-induced changes in gut microbiota composition. Among exogenous factors shaping the gut microbiome, diet appears to have the largest effect.
[124] Cani PD, Amar J, Iglesias MA et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007. Link
Bacterial lipopolysaccharide (LPS) is identified as a triggering factor for insulin resistance, obesity and diabetes. Plasma LPS fluctuates with feeding/fasting and a 4-week high-fat diet chronically increased it 2-3-fold ("metabolic endotoxemia") while increasing the proportion of LPS-containing gut microbiota. Inducing comparable metabolic endotoxemia in mice via continuous subcutaneous LPS infusion for 4 weeks reproduced the high-fat-diet phenotype: increased fasting glycaemia and insulinaemia, weight gain, adipose F4/80+ inflammation, and hepatic triglyceride accumulation.